|
2013
|
Invention
|
Type b lantibiotic nvb302 for the treatment of c. difficile infection. The inventions provides a ... |
|
2012
|
Invention
|
Polymyxin derivatives. Provided are compounds, the use of the said compounds in treatment, for ex... |
|
|
Invention
|
Compounds. C. difficile, especially infection of the colon and/or lower intestines and diarrhea a... |
|
2011
|
Invention
|
Formulations for infusion of type b lantibiotics. A liquid colloidal pharmaceutical formulation o... |
|
|
Invention
|
Compounds. Described is a compound of formula (I): wherein X represents a bond or an amino acid r... |
|
|
Invention
|
Compounds. Described is a compound of formula (I): where R4 represents -RA-L-Ar1, formula (II): o... |
|
|
Invention
|
Formulations for infusion of type b lantibiotics. Described is a A liquid colloidal pharmaceutica... |
|
|
Invention
|
Formulation comprising a type b lantibiotic.
Described is a pharmaceutical formulation of a caps... |
|
|
Invention
|
Formulation comprising a type b lantibiotic. Described is a pharmaceutical formulation of a capsu... |
|
|
Invention
|
A. liguriae . Characterization of the biosynthetic gene cluster for the lantibiotic antibiotic ac... |
|
|
Invention
|
Lantibiotic salts.
Described are certain salts of certain lantibiotic compounds, pharmaceutical ... |
|
|
Invention
|
Actagardine derivatives, and pharmaceutical use thereof. Micrococcus luteus infection. The lantib... |
|
|
Invention
|
Actagardine derivatives, and pharmaceutical use thereof. Described are lantibiotic-based compound... |
|
|
Invention
|
Lantibiotic salts. Described are certain salts of certain lantibiotic compounds, pharmaceutical c... |
|
2010
|
Invention
|
Compounds. 1, p and Z have the values disclosed herein.
|
|
|
Invention
|
Actagardine derivatives. The present disclosure relates to compounds of formula (II): pharmaceuti... |
|
|
Invention
|
Actagardine derivatives. The present disclosure relates to compounds of formula (II): pharm... |
|
|
Invention
|
Deoxyactagardine derivatives. The present invention pertains generally to certain compounds... |
|
|
Invention
|
Deoxyactagardine derivatives. The present invention pertains generally to certain compounds of th... |
|
|
Invention
|
Actagardine derivatives, and pharmaceutical use thereof. The present invention pertains generally... |
|
2009
|
Invention
|
Use of type-b lantibiotic-based compounds having antimicrobial activity. A method for the treatme... |
|
2008
|
Invention
|
A. liguriae . Characterization of the biosynthetic gene cluster for the lantibiotic actagardine, ... |
|
|
Invention
|
The use of type-b lantibiotic-based compounds having antimicrobial activity. The present inventio... |
|
|
Invention
|
Lantibiotic-based compounds having antimicrobial activity. The present invention provides actagar... |
|
|
Invention
|
Method for the chemo-selective enzymatic hydrolysis if a diester compound for preparing a monoest... |
|
2007
|
Invention
|
In situ or one-pot hydrogenation and reductive amination method. The invention relates to a metho... |
|
|
Invention
|
Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae. This inventio... |
|
|
Invention
|
Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae. This invention rela... |
|
2006
|
Invention
|
Variants of the lantibiotic mersacidin and their use. This invention relates to variants of... |
|
|
Invention
|
Variants of the lantibiotic mersacidin and their use. This invention relates to variants of the l... |
|
|
Invention
|
F3w variants of the lantibiotic mersacidin and its use. Bacillus HIL host cell with plasmid, whic... |
|
2005
|
Invention
|
Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells. The p... |
